Dynatronics Faces Leadership Change and Economic Challenges

An update from Dynatronics ( (DYNT) ) is now available.

Dynatronics Corporation, a prominent medical device company, announced the resignation of director Brian M. Larkin, who had contributed significantly to the company’s strategy and commercial planning since 2015. Despite this change, Dynatronics reported a net loss of $2.7 million for fiscal year 2024, with total net sales amounting to $32.5 million and a gross profit margin of 23.5%. The company remains focused on introducing new products, optimizing inventory levels, and enhancing customer service, while facing economic challenges such as increased raw material costs and supply chain disruptions.

See more insights into DYNT stock on TipRanks’ Stock Analysis page.